证券代码：301196 证券简称：唯科科技 公告编号：2025-038 厦门唯科模塑科技股份有限公司 第二届董事会第十七次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、 误导性陈述或重大遗漏。 厦门唯科模塑科技股份有限公司（以下简称"公司"）第二届董事会第十七 次会议于 2025 年 8 月 25 日在厦门火炬高新区（翔安）产业区春光路 1152 号-1156 号（双号）公司会议室以现场表决和电子通讯相结合的方式召开，会议通知已于 2025 年 8 月 14 日以现场送达和电子邮件的形式向全体董事发出，本次会议由董 事长庄辉阳召集和主持，应到董事 8 名，实际出席董事 8 名，公司高级管理人员 列席了本次会议。本次会议的召集和召开符合《公司法》等相关法律、行政法规、 规范性文件及《公司章程》《董事会议事规则》等有关规定。 一、董事会会议审议情况 经与会董事审议，一致通过以下决议： 1、审议通过《关于<2025 年半年度报告>全文及摘要的议案》 经审议，董事会认为：公司编制的《2025 年半年度报告》全文及摘要符合 相关法律法规的规定，报告内容真实、准确、完整地反映了公司 ...

证券代码：301196 证券简称：唯科科技 公告编号：2025-042 厦门唯科模塑科技股份有限公司 关于调整 2022 年限制性股票激励计划授予价格的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、 误导性陈述或重大遗漏。 厦门唯科模塑科技股份有限公司（以下简称"公司"）于 2025 年 8 月 25 日 召开了第二届董事会第十七次会议，审议通过了《关于调整 2022 年限制性股票 激励计划授予价格的议案》，同意将 2022 年限制性股票激励计划授予价格（含 预留）由 15.82 元/股调整为 15.22 元/股。现将有关事项说明如下： 一、本次激励计划已履行的相关审批程序 （一）2022 年 12 月 25 日，公司召开第一届董事会第二十一次会议，审议 通过了《关于<2022 年限制性股票激励计划（草案）>及其摘要的议案》《关于 <2022 年限制性股票激励计划实施考核管理办法>的议案》《关于提请股东大会 授权董事会办理股权激励相关事宜的议案》等相关议案，公司独立董事就本次激 励计划是否有利于公司的持续发展及是否存在损害公司及全体股东利益的情形 发表了独立意见。 同日，公司召 ...

国金证券股份有限公司 关于厦门唯科模塑科技股份有限公司 出售部分募投项目设备暨以自有资金置换已投入募集资金 并归还募集资金专户事项的核查意见 国金证券股份有限公司（以下简称"保荐机构"）为厦门唯科模塑科技股份 有限公司（以下简称"唯科科技"或"公司"）首次公开发行股票并在创业板上 市的保荐机构，根据《证券发行上市保荐业务管理办法》、《深圳证券交易所创 业板股票上市规则》、《深圳证券交易所上市公司自律监管指引第 2 号——创业 板上市公司规范运作》、《上市公司募集资金监管规则》等有关规定，对唯科科 技出售部分募投项目设备暨以自有资金置换已投入募集资金并归还募集资金专 户的事项进行了核查，核查情况如下： | 二、交易标的基本情况 | | --- | | 序号 | 项目名称 | 设备名称 | 数量 | 总价 （万元） | 实际已支付需置 换的金额（万元） | | --- | --- | --- | --- | --- | --- | | 1 | 唯科模塑智能 制造项目 | 注塑机-700T | 1 | 221.69 | 217.49 | | | | 齿轮测量仪 | 1 | | | 1 | | | 机械手 标准螺丝机 ...

国浩律师（上海）事务所 关于厦门唯科模塑科技股份有限公司 调整 2022 年限制性股票激励计划授予价格 之 法律意见书 上海市山西北路 99 号苏河湾中心 MT25-28 层 邮编：200082 25-28/F, Suhe Centre, 99 North Shanxi Road, Jing'an District, Shanghai, China 电话/Tel: (+86)(21) 5234 1668 传真/Fax: (+86)(21) 5243 1670 网址/Website: http://www.grandall.com.cn 二〇二五年八月 | 释 义 .. | | --- | | 第一节 引言 . | | 第二节 正文 . | | 一、本次激励计划的批准和授权 | | 二、关于本次调整事由及方法 | | 三、本次激励计划的信息披露 | | 1 - 1 - 5 四、结论意见 . | | 第三节 签署页 | 国浩律师（上海）事务所 法律意见书 释 义 除非另有说明，本法律意见书中相关词语具有以下特定含义： | 唯科科技、公司、本公司、 | 指 | 厦门唯科模塑科技股份有限公司 | | --- | -- ...

国金证券股份有限公司 关于厦门唯科模塑科技股份有限公司 使用剩余超募资金永久补充流动资金事项的核查意见 国金证券股份有限公司（以下简称"保荐机构"）为厦门唯科模塑科技股份 有限公司（以下简称"唯科科技"或"公司"）首次公开发行股票并在创业板上 市的保荐机构，根据《证券发行上市保荐业务管理办法》、《深圳证券交易所创 业板股票上市规则》、《深圳证券交易所上市公司自律监管指引第 2 号——创业 板上市公司规范运作》、《上市公司募集资金监管规则》等有关规定，对唯科科 技使用剩余超募资金永久补充流动资金的事项进行了核查，核查情况如下： 一、募集资金基本情况 中国证监会 2021 年 12 月 1 日核发了《关于同意厦门唯科模塑科技股份有限 公司首次公开发行股票注册的批复》（证监许可[2021]3798 号），同意公司首次 公开发行股票的注册申请。根据上述批复，公司公开发行人民币普通股（A 股） 股票3,120 万股，发行价格为 64.08元/股，募集资金总额为人民币 1,999,296,000.00 元，扣除与发行有关的费用（不含税）人民币 243,467,806.44 元后，实际募集资 金净额为人民币 1,755,8 ...

国金证券股份有限公司 | 保荐机构名称：国金证券股份有限公司 | 被保荐公司简称：唯科科技 | | --- | --- | | 保荐代表人姓名：傅志锋 | 联系电话：0592-5350605 | | 保荐代表人姓名：俞琳 | 联系电话：0592-5350605 | | 事项 | 存在的问题 | 采取的措施 | | --- | --- | --- | | 1.信息披露 | 无 | 不适用 | | 2.公司内部制度的建立和执行 | 无 | 不适用 | | 3."三会"运作 | 无 | 不适用 | | 4.控股股东及实际控制人变动 | 无 | 不适用 | | 5.募集资金存放及使用 | 无 | 不适用 | | 6.关联交易 | 无 | 不适用 | | 7.对外担保 | 无 | 不适用 | | 8.收购、出售资产 | 无 | 不适用 | | 9.其他业务类别重要事项（包括对外投资、风 险投资、委托理财、财务资助、套期保值等） | 无 | 不适用 | | 10.发行人或者其聘请的中介机构配合保荐 | 无 | 不适用 | | 工作的情况 | | | | 11.其他（包括经营环境、业务发展、财务状 况、管理状况、核心技术等 ...

Financial Performance - The company's revenue for the reporting period reached ¥1,086,917,032.43, representing a 33.51% increase compared to ¥814,122,080.66 in the same period last year[18]. - Net profit attributable to shareholders was ¥148,628,180.36, up 30.71% from ¥113,708,161.05 year-on-year[18]. - The net profit after deducting non-recurring gains and losses surged by 90.51% to ¥135,737,516.61 from ¥71,250,032.98 in the previous year[18]. - The net cash flow from operating activities increased significantly by 285.13%, amounting to ¥162,409,500.51 compared to ¥42,170,331.45 last year[18]. - Basic earnings per share rose to ¥1.1962, a 31.29% increase from ¥0.9111 in the same period last year[18]. - Total assets at the end of the reporting period were ¥4,166,013,793.15, reflecting a 6.31% increase from ¥3,918,827,588.40 at the end of the previous year[18]. - The net assets attributable to shareholders increased by 5.98% to ¥3,306,052,786.80 from ¥3,119,631,283.07 at the end of the last year[18]. - The weighted average return on net assets improved to 4.64%, up from 3.64% in the previous year[18]. Risk Management - The company emphasizes the importance of risk awareness regarding future strategic goals and operational plans[3]. - The report includes a section on risks faced by the company and corresponding countermeasures[3]. - The company faces risks from fluctuating labor costs and raw material prices, which may lead to a decline in gross margin[90]. Governance and Compliance - The financial report ensures the accuracy and completeness of the financial statements, with all board members present for the review[3]. - The report outlines the company's commitment to transparency and legal responsibility regarding financial disclosures[3]. - The company is focused on maintaining a strong governance structure, as indicated by the absence of a supervisory board following a resolution[9]. - The company has implemented measures to protect investor rights and enhance transparency through various communication channels[111]. - The company has a commitment to comply with legal regulations regarding shareholding and share changes, with penalties for violations[118]. Research and Development - The company is actively engaged in research and development of new products and technologies, although specific details are not provided in the current documents[3]. - The company has invested in R&D, holding a total of 532 authorized patents, including 36 invention patents, which supports its long-term competitive advantage[44]. - The company invested ¥49,359,872.51 in R&D, marking a 34.04% increase as a result of expanding research projects[54]. Market Presence and Expansion - The company has subsidiaries in various regions, including Malaysia, Mexico, and Vietnam, indicating a broad market presence[9]. - The company has established production bases in multiple countries, including Germany, Malaysia, Mexico, and Vietnam, enhancing its international market presence[47]. - The company has established subsidiaries in the United States and Singapore since August 2023 as part of its marketing service network construction[79]. Product and Service Offerings - The company has expanded its business to include the production and sales of injection-molded parts and health products, becoming a "mold-integration" large-scale production enterprise[25]. - The company has a diverse product line including precision injection molds, injection-molded parts, and health products primarily focused on air purifiers[25]. - The production of precision injection molds is customized and follows an order-based production model, ensuring alignment with customer specifications[40]. - The health products are produced using a combination of ODM and OEM models, allowing for flexibility in design and production based on customer requirements[40]. Financial Management - Cash and cash equivalents increased to ¥553.80 million, representing 13.29% of total assets, up from 11.25% last year, a change of 2.04%[59]. - Accounts receivable stood at ¥471.87 million, accounting for 11.33% of total assets, a slight decrease of 0.17% from the previous year[59]. - Inventory rose to ¥426.93 million, making up 10.25% of total assets, an increase of 0.07% compared to last year[59]. - Investment income amounted to ¥17.74 million, contributing 10.43% to total profit, primarily from bank wealth management products and long-term equity investments[60]. - The company reported an asset impairment of -¥8.68 million, which is -5.10% of total profit, mainly due to inventory write-downs[60]. Shareholder and Equity Management - The company reported a plan not to distribute cash dividends, issue bonus shares, or increase capital from reserves[4]. - The company has fulfilled its shareholding commitments made during the initial public offering or financing, with several commitments completed by July 2023[114]. - The company will not repurchase shares held before the IPO during the lock-up period[118]. - The company has a commitment to disclose control arrangements if shares are reduced after the lock-up period[117]. Investor Relations - The company has conducted multiple investor relations activities, including on-site research meetings with various institutional investors throughout January to May 2025[93][95]. - The company is focusing on future development plans discussed during investor meetings, indicating a strategic direction for growth[93][95]. - The company has engaged with a wide range of institutional investors, including major funds and securities firms, to discuss business operations and future strategies[93][95]. Asset Management - The total number of shares increased from 124,800,000 to 125,256,497, reflecting an increase of 456,497 shares due to stock incentives[177]. - The number of restricted shares decreased from 87,482,712 (70.10%) to 57,579,225 (45.97%), a reduction of 29,903,487 shares[171]. - The number of unrestricted shares increased from 37,317,288 (29.90%) to 67,677,272 (54.03%), an increase of 30,359,984 shares[171]. - The company repurchased a total of 1,857,775 shares, representing 1.49% of the total share capital, with a total expenditure of approximately ¥50.22 million[175].

Group 1: Chemical and Oil Industry Performance - The chemical index and oil index experienced an overall increase last week, with the chemical raw materials index rising by 3.29%, the chemical machinery index by 0.78%, the chemical pharmaceuticals index by 0.04%, and the pesticide and fertilizer index by 1.90% [1] - In the oil sector, the oil processing index increased by 4.14%, the oil extraction index by 0.70%, and the oil trading index by 2.97% [1] - International crude oil prices showed a strong performance, with WTI settling at $63.66 per barrel, up 1.37% from August 15, and Brent settling at $67.73 per barrel, up 2.85% [1] Group 2: Market Performance of Chemical Companies - The top five performing chemical companies included Zhenan Technology with a rise of 53.11%, Feilu Co. with 33.16%, Qide New Materials with 30.05%, Honghe Technology with 23.25%, and Jinmei B shares with 21.35% [2] - The five chemical companies with the largest declines were Shangwei New Materials down 13.12%, Weike Technology down 10.89%, Xinya Qiang down 10.59%, Zhongxin Fluorine Materials down 10.38%, and Jiuding New Materials down 9.15% [2] Group 3: Commodity Price Changes - The top five products with the highest price increases included Vitamin B1 up 12.82%, Vitamin D3 up 7.14%, Paraquat up 6.56%, industrial-grade lithium carbonate up 4.90%, and propane up 4.84% [1] - The five products with the largest price decreases were liquid chlorine down 48.51%, hydrochloric acid down 8.29%, butyl rubber down 7.79%, methyl acrylate down 7.33%, and butyl acrylate down 6.13% [1]

证券日报网讯唯科科技8月22日在互动平台回答投资者提问时表示，截至2025年8月20日，公司股东总户 数为15，800户。 ...

Group 1: Chemical Sector Performance - The chemical index experienced a significant increase, with the chemical raw materials index rising by 2.81%, the chemical machinery index by 1.53%, the chemical pharmaceuticals index by 3.70%, and the pesticide and fertilizer index by 1.03% [1] - In contrast, the oil index saw a decline across all categories, with the oil processing index down by 1.10%, the oil extraction index down by 1.22%, and the oil trading index down by 1.02% [1] Group 2: Oil Prices - International crude oil prices showed weakness, with the WTI crude oil futures settling at $62.80 per barrel, a decrease of 1.69% from August 8, and Brent crude oil futures settling at $65.85 per barrel, down by 1.11% [1] Group 3: Petrochemical Product Price Changes - The top five petrochemical products with price increases included liquid chlorine up by 29.05%, battery-grade lithium carbonate up by 18.57%, industrial-grade lithium carbonate up by 14.53%, folic acid up by 6.38%, and niacinamide up by 5.00% [1] - Conversely, the top five petrochemical products with price declines included butanone down by 8.91%, organic silicon DMC down by 8%, organic silicon D4 down by 7.69%, raw rubber down by 7.41%, and synthetic ammonia down by 6.95% [1] Group 4: Capital Market Performance of Chemical Companies - The top five listed chemical companies with the highest stock price increases were Shuangyi Technology up by 41.17%, Kaimete Gas up by 34.73%, Honghe Technology up by 33.09%, Weike Technology up by 31.54%, and Xinhang New Materials up by 31.43% [2] - The bottom five listed chemical companies with the largest stock price declines were Zhizheng Co. down by 13.04%, Donghua Energy down by 11.49%, Renzhi Co. down by 10%, Fengshan Group down by 8.51%, and Hehua Co. down by 8.20% [2]